These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2853605)

  • 1. Lambert-Eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulation.
    Nagel A; Engel AG; Lang B; Newsom-Davis J; Fukuoka T
    Ann Neurol; 1988 Oct; 24(4):552-8. PubMed ID: 2853605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lambert-Eaton myasthenic syndrome: II. Immunoelectron microscopy localization of IgG at the mouse motor end-plate.
    Fukuoka T; Engel AG; Lang B; Newsom-Davis J; Vincent A
    Ann Neurol; 1987 Aug; 22(2):200-11. PubMed ID: 3310854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lambert-Eaton myasthenic syndrome: I. Early morphological effects of IgG on the presynaptic membrane active zones.
    Fukuoka T; Engel AG; Lang B; Newsom-Davis J; Prior C; Wray DW
    Ann Neurol; 1987 Aug; 22(2):193-9. PubMed ID: 3662451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lambert-Eaton myasthenic syndrome: immunoglobulin G inhibition of Ca2+ flux in tumor cells correlates with disease severity.
    Lang B; Vincent A; Murray NM; Newsom-Davis J
    Ann Neurol; 1989 Mar; 25(3):265-71. PubMed ID: 2543262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones.
    Fukunaga H; Engel AG; Lang B; Newsom-Davis J; Vincent A
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7636-40. PubMed ID: 6584877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lambert-Eaton myasthenic syndrome: a review.
    Newsom-Davis J
    Monogr Allergy; 1988; 25():116-24. PubMed ID: 2845259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins.
    Buchwald B; Ahangari R; Weishaupt A; Toyka KV
    Muscle Nerve; 2005 Apr; 31(4):487-94. PubMed ID: 15685615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse.
    Waterman SA; Lang B; Newsom-Davis J
    Ann Neurol; 1997 Aug; 42(2):147-56. PubMed ID: 9266723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals.
    Prior C; Lang B; Wray D; Newsom-Davis J
    Ann Neurol; 1985 Jun; 17(6):587-92. PubMed ID: 2992356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-linking of presynaptic calcium channels: a mechanism of action for Lambert-Eaton myasthenic syndrome antibodies at the mouse neuromuscular junction.
    Peers C; Johnston I; Lang B; Wray D
    Neurosci Lett; 1993 Apr; 153(1):45-8. PubMed ID: 8390031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
    Takamori M
    J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
    Lang B; Pinto A; Giovannini F; Newsom-Davis J; Vincent A
    Ann N Y Acad Sci; 2003 Sep; 998():187-95. PubMed ID: 14592874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lambert-Eaton myasthenic syndrome: electrophysiological evidence for a humoral factor.
    Newsom-Davis J; Murray N; Wray D; Lang B; Prior C; Gwilt M; Vincent A
    Muscle Nerve; 1982; 5(9S):S17-20. PubMed ID: 6302493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulations of active zone structure and function at mammalian NMJs predict that loss of calcium channels alone is not sufficient to replicate LEMS effects.
    Ginebaugh SP; Badawi Y; Laghaei R; Mersky G; Wallace CJ; Tarr TB; Kaufhold C; Reddel S; Meriney SD
    J Neurophysiol; 2023 May; 129(5):1259-1277. PubMed ID: 37073966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder.
    Vincent A; Lang B; Newsom-Davis J
    Trends Neurosci; 1989 Dec; 12(12):496-502. PubMed ID: 2480664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lambert-Eaton myasthenic syndrome: diagnosis and treatment].
    Motomura M; Iwanaga H
    Clin Calcium; 2001 Nov; 11(11):1468-74. PubMed ID: 15775666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lambert-eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel.
    Pellkofer HL; Armbruster L; Krumbholz M; Titulaer MJ; Verschuuren JJ; Schumm F; Voltz R
    J Neuroimmunol; 2008 Nov; 204(1-2):136-9. PubMed ID: 18809213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of Lambert-Eaton myasthenic syndrome immunoglobulin for nerve terminal calcium channels.
    Hewett SJ; Atchison WD
    Brain Res; 1992 Dec; 599(2):324-32. PubMed ID: 1363289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulins of Lambert-Eaton myasthenic syndrome inhibit rat pituitary hormone release.
    Login IS; Kim YI; Judd AM; Spangelo BL; MacLeod RM
    Ann Neurol; 1987 Nov; 22(5):610-4. PubMed ID: 3122645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.